| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/25/2008 | CN101204392A Self-emulsifying microemulsion daidzein oral liquid preparation composite and preparation method thereof |
| 06/25/2008 | CN101204390A Paclitaxel mainline menstruum and application programme thereof |
| 06/25/2008 | CN101204387A Novel tamsulosin hydrochloride sustained release capsules |
| 06/25/2008 | CN101204386A Liquid composite containing salbutamol sulfate and ambroxol hydrochloride |
| 06/25/2008 | CN101204385A Child soluble amantadine hydrochloride troche |
| 06/25/2008 | CN101204384A Selective estrogen receptor modulator reducing lipide characteristic |
| 06/25/2008 | CN101204383A Manufacturing apparatus of transdermal absorption preparation |
| 06/25/2008 | CN101204382A Mitomycin double sustained release film of implanted antineoplastic agents and its preparation method |
| 06/25/2008 | CN101204381A Band Aid |
| 06/25/2008 | CN101204380A Sustained-release coated pellets for 24 hours |
| 06/25/2008 | CN101204379A Ambroxol cefadroxil dispersible tablets |
| 06/25/2008 | CN101204378A Memantine hydrochloride oral medicine compound and its preparation method |
| 06/25/2008 | CN101204377A Novel cryoprotectants prescription for treatment of botulinum toxin a freeze-dried powder and injection preparation |
| 06/25/2008 | CN101204376A Oxaliplatin freeze-dried powder and injection preparation method thereof |
| 06/25/2008 | CN101204375A Strontium ranelate dry suspension |
| 06/25/2008 | CN101204374A Coating compound polyvalent high efficient yolk antibody |
| 06/25/2008 | CN101204373A Paclitaxel lipid microspheres injection and preparation method thereof |
| 06/25/2008 | CN101204372A Cinepazide maleate injection and preparation method thereof |
| 06/25/2008 | CN101204371A Vitamin C injection and preparation method thereof |
| 06/25/2008 | CN101204370A Zolinza sustained-release implant treating for solid tumor |
| 06/25/2008 | CN101204369A Sorafenib sustained-release implant treating for solid tumor |
| 06/25/2008 | CN101204368A Pirarubicin sustained-release implant treating for solid tumor |
| 06/25/2008 | CN101204367A Axitinib sustained-release implplant treating for solid tumor |
| 06/25/2008 | CN101204366A Melphalan sustained-release implant treating for solid tumor |
| 06/25/2008 | CN101204365A Implant agent treating for solid tumor |
| 06/25/2008 | CN101204364A Delivery system and application of chitosan mucosa compromising mucosal adjuvant |
| 06/25/2008 | CN101204341A Postpartum gynae rehabilitation tourniquet and its preparation method thereo |
| 06/25/2008 | CN101204228A Processing method for dried black fungus fiber, colloid and beta-carotene |
| 06/25/2008 | CN100396688C Cephems phosphate and preparation process and use thereof |
| 06/25/2008 | CN100396390C Surface treatment method and instrument of air bubble utilizing backing |
| 06/25/2008 | CN100396344C Applicator for administering preparation of liquid or semi-solid to sufferer mucosa cavity |
| 06/25/2008 | CN100396334C Process to improve stability of pharmaceutical compsn |
| 06/25/2008 | CN100396332C Quickly soluble film preparations |
| 06/25/2008 | CN100396329C Suspension of an EPI-HNE protein, process of preparation thereof, dry powder aerosol derived therefrom, pharmaceutical composition containing said suspension or aerosol, and their uses |
| 06/25/2008 | CN100396327C Use of composition in preparing antifatigue medicament |
| 06/25/2008 | CN100396320C Oral liquid and capsules of Chinese medicine for diabete by supplementing Qi and nourishing Yin and promotnig production of body fluid and quenching thirst |
| 06/25/2008 | CN100396317C Medicinal preparation for treating hepatitis B and its preparation method |
| 06/25/2008 | CN100396315C Oral Chinese medicine for treating and preventing recurrence of uecerative stomatitis |
| 06/25/2008 | CN100396314C Chinese medicine for treating cholecystitis |
| 06/25/2008 | CN100396308C Xianlinggubao soft capsule for treating osteoporosis and its preparing method |
| 06/25/2008 | CN100396305C Chinese medicinal preparation for treating hyperosteogeny and lumbar vertebra protrusion |
| 06/25/2008 | CN100396303C Deer fetus-pearl capsule |
| 06/25/2008 | CN100396300C Chinese traditional medicine for treating enteritis and appendicitis, and method for preparing same |
| 06/25/2008 | CN100396297C Composition of Chinese traditional medicine for treating cardiovascular diseases |
| 06/25/2008 | CN100396295C Medicine for treating virus hepatitis |
| 06/25/2008 | CN100396294C Application of resina ferulae in preparation of medicament for treating irritable bowel syndrome(IBS) |
| 06/25/2008 | CN100396292C Traditional Chinese medicine powder for treating cervical erosio |
| 06/25/2008 | CN100396291C Injection of calf blood de-protein extract and preparation method thereof |
| 06/25/2008 | CN100396290C External use anti-bacteria foaming agent for gynecology |
| 06/25/2008 | CN100396289C Scutellarin injection preparation and its preparing method |
| 06/25/2008 | CN100396287C Formulation containing phosphate derivatives of electron transfer agents |
| 06/25/2008 | CN100396285C Inhalative solution formulation containing tiotropium salt |
| 06/25/2008 | CN100396284C Novel galneical form for oral administration with prolonged release of molsidomine |
| 06/25/2008 | CN100396282C Slow released doxazosin mesilate capsule and its preparation process |
| 06/25/2008 | CN100396281C Use of rotigotine for treating the restless leg syndrome |
| 06/25/2008 | CN100396280C Application of asafetida and volatile asafetida oil in preparing anticancer medicine |
| 06/25/2008 | CN100396279C Chinese medicinal preparation for treating arrhythmia and its preparation method |
| 06/25/2008 | CN100396278C Medicinal micro pill core and its preparing method |
| 06/25/2008 | CN100396277C Method for preparing a compound of interaction of active substances with a porous support using supercritical fluid |
| 06/25/2008 | CN100396276C Compositions containing organic compounds |
| 06/25/2008 | CN100396264C Labial product system to maintain a treatment agent |
| 06/24/2008 | US7392141 Polypeptides; genetic engineering |
| 06/24/2008 | US7390793 Have fixed, preselected hydrodynamic diameters and are formed from basic or acidic amphiphilic compounds; compound E5564 and derivatives |
| 06/24/2008 | US7390783 Charged phospholipid compositions and methods for their use |
| 06/24/2008 | US7390780 For transfecting nucleic acids in vivo or ex vivo; vesicle forming lipid and hydrophilic polymer; gene therapy |
| 06/24/2008 | US7390668 Halogenated xanthan compound |
| 06/24/2008 | US7390628 Microparticle-based diagnostic methods |
| 06/24/2008 | US7390519 Probiotic Lactobacillus salivarius strains |
| 06/24/2008 | US7390518 Mixture containing cyclodextrin ; removing stains from teeth |
| 06/24/2008 | US7390508 Xenon is administered with an anesthetic selected from isoflurane, sevoflurane, and desflurane; treating hypoxic-ischemic (HI) insult |
| 06/24/2008 | US7390506 Substituted or unsubstituted 5-nitrothiazole covalently attached to a lipid selected from fatty acids or esters; oral administration; parasitic, bacterial, viral, or fungal infections; equine protozoal myeloencephalitis (EPM) or coccidiosis; drug delivery, nontoxic, bioavailability |
| 06/24/2008 | US7390505 Nanoparticulate topiramate formulations |
| 06/24/2008 | US7390504 HDL-boosting combination therapy complexes |
| 06/24/2008 | US7390503 Ondansetron orally disintegrating tablets |
| 06/24/2008 | US7390502 Administering a mammalian host for treating a disease caused by proliferation of eukaryotic cells a formulation containing a complex of lipid and a drug 7-ethyl-10-hydroxycamptothecin |
| 06/24/2008 | US7390500 Transdermal therapeutic system (TTS) with fentanyl as a active ingredient |
| 06/24/2008 | US7390411 Method for preparing a compound of interaction of active substances with a porous support using supercritical fluid |
| 06/21/2008 | WO2007068311A1 Oral delivery of protein drug using microemulsion |
| 06/21/2008 | CA2672707A1 Oral delivery of protein drug using microemulsion |
| 06/21/2008 | CA2571897A1 Controlled extended drug release technology |
| 06/20/2008 | CA2613558A1 Manufacturing apparatus of transdermal absorption preparation |
| 06/19/2008 | WO2008073779A2 Compositions and methods for treating seizures |
| 06/19/2008 | WO2008073759A2 An article comprising prasugrel |
| 06/19/2008 | WO2008073731A2 Microemulsion dosage forms of valsartan and methods of making the same |
| 06/19/2008 | WO2008073642A2 Protein microspheres retaining pharmacokinetic and pharmacodynamic properties |
| 06/19/2008 | WO2008073614A2 Composition and method for enhancing skin cell growth, proliferation and repair |
| 06/19/2008 | WO2008073558A2 Water-dispersible oral, parenteral, and topical formulations for poorly water soluble drugs using smart polymeric nanoparticles |
| 06/19/2008 | WO2008073388A2 Alfuzosin formulations, methods of making and methods of use |
| 06/19/2008 | WO2008073324A1 Topical eutectic anesthetic composition for oral or dermal tissue |
| 06/19/2008 | WO2008073282A2 Ph sensitive matrix formulation |
| 06/19/2008 | WO2008073230A1 Liposome containing cardiolipin for improvement of mitochondrial function |
| 06/19/2008 | WO2008073193A2 Ocular devices and methods of making and using thereof |
| 06/19/2008 | WO2008072988A1 Honey based compositions of a consistency that can be delivered to the respiratory system |
| 06/19/2008 | WO2008072960A1 Extended release excipient and its use |
| 06/19/2008 | WO2008072954A2 Liposomes containing a polyphenol derivative such as caffeic acid and a method of post-loading thereof |
| 06/19/2008 | WO2008072953A1 Statin containing compositions for treatment of cancer |
| 06/19/2008 | WO2008072952A2 Anti-inflammatory compounds containing compositions for treatment of cancer |
| 06/19/2008 | WO2008072869A1 Plaster composition comprising alendronate as an effective ingredient for treating osteoporosis |
| 06/19/2008 | WO2008072584A1 Liposome encapsulating ammine-platinum complex at high concentration, and method for production of the liposome |
| 06/19/2008 | WO2008072535A1 Pharmaceutical composition containing low-substituted hydroxypropylcellulose |